Next Article in Journal
The Prognostic Impact of p53 Expression on Sporadic Colorectal Cancer Is Dependent on p21 Status
Next Article in Special Issue
Epidermal Growth Factor Receptor in Pancreatic Cancer
Previous Article in Journal
Cancer Stem Cell Radioresistance and Enrichment: Where Frontline Radiation Therapy May Fail in Lung and Esophageal Cancers
Previous Article in Special Issue
Tissue Transglutaminase (TG2)-Induced Inflammation in Initiation, Progression, and Pathogenesis of Pancreatic Cancer
Article Menu

Export Article

Open AccessReview
Cancers 2011, 3(1), 1253-1273;

Current State of Surgical Management of Pancreatic Cancer

Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Im Neuenheimer Feld 110, 69120 Heidelberg, Germany
Author to whom correspondence should be addressed.
Received: 10 February 2011 / Revised: 19 February 2011 / Accepted: 10 March 2011 / Published: 10 March 2011
(This article belongs to the Special Issue Pancreatic Cancer)
Full-Text   |   PDF [444 KB, uploaded 11 March 2011]   |  


Pancreatic cancer is still associated with a poor prognosis and remains—as the fourth leading cause of cancer related mortality—a therapeutic challenge. Overall long-term survival is about 1–5%, and in only 10–20% of pancreatic cancer patients is potentially curative surgery possible, increasing five-year survival rates to approximately 20–25%. Pancreatic surgery is a technically challenging procedure and has significantly changed during the past decades with regard to technical aspects as well as perioperative care. Standardized resections can be carried out with low morbidity and mortality below 5% in high volume institutions. Furthermore, there is growing evidence that also more extended resections including multivisceral approaches, vessel reconstructions or surgery for tumor recurrence can be carried out safely with favorable outcomes. The impact of adjuvant treatment, especially chemotherapy, has increased dramatically within recent years, leading to significantly improved postoperative survival, making pancreatic cancer therapy an interdisciplinary approach to achieve best results. View Full-Text
Keywords: pancreatic cancer; surgery; standard resection; extended approach pancreatic cancer; surgery; standard resection; extended approach

Graphical abstract

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

MDPI and ACS Style

Hackert, T.; Büchler, M.W.; Werner, J. Current State of Surgical Management of Pancreatic Cancer. Cancers 2011, 3, 1253-1273.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top